Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Sanderson

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
International Journal of Colorectal Disease|September 1, 2006
Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British populationAlexandra V Pearce, Sheila A Fisher, Natalie J Prescott, et al.
Scientific Reports|January 2, 2020
Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic backgroundSara Falcone, Laura Wisby, Thomas Nicol, et al.
Plos One|October 31, 2014
Effect of breadmaking process on in vitro gut microbiota parameters in irritable bowel syndromeAdele Costabile, Sara Santarelli, Sandrine P Claus, et al.
BMC Public Health|January 21, 2011
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smokingSophia C L Whitwell, Christopher G Mathew, Cathryn M Lewis, et al.
Human Genetics|October 18, 2002
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiencySatoshi Sumi, Anthony M Marinaki, Monica Arenas, et al.
Journal of Functional Foods|October 17, 2017
<i>In vitro</i> and <i>in vivo</i> modeling of lipid bioaccessibility and digestion from almond muffins: The importance of the cell-wall barrier mechanismTerri Grassby, Giuseppina Mandalari, Myriam M-L Grundy, et al.
Gastroenterology|March 23, 2002
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel diseaseAndrew P Cuthbert, Sheila A Fisher, Muddassar M Mirza, et al.
Pharmacogenetics|February 4, 2003
Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and CaucasiansAnthony M Marinaki, Monica Arenas, Zubair H Khan, et al.
American Journal of Human Genetics|March 6, 2003
Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn diseaseMuddassar M Mirza, Sheila A Fisher, Kathy King, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
International Journal of Colorectal Disease|September 1, 2006
Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British populationAlexandra V Pearce, Sheila A Fisher, Natalie J Prescott, et al.
Scientific Reports|January 2, 2020
Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic backgroundSara Falcone, Laura Wisby, Thomas Nicol, et al.
Plos One|October 31, 2014
Effect of breadmaking process on in vitro gut microbiota parameters in irritable bowel syndromeAdele Costabile, Sara Santarelli, Sandrine P Claus, et al.
BMC Public Health|January 21, 2011
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smokingSophia C L Whitwell, Christopher G Mathew, Cathryn M Lewis, et al.
Human Genetics|October 18, 2002
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiencySatoshi Sumi, Anthony M Marinaki, Monica Arenas, et al.
Journal of Functional Foods|October 17, 2017
<i>In vitro</i> and <i>in vivo</i> modeling of lipid bioaccessibility and digestion from almond muffins: The importance of the cell-wall barrier mechanismTerri Grassby, Giuseppina Mandalari, Myriam M-L Grundy, et al.
Gastroenterology|March 23, 2002
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel diseaseAndrew P Cuthbert, Sheila A Fisher, Muddassar M Mirza, et al.
Pharmacogenetics|February 4, 2003
Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and CaucasiansAnthony M Marinaki, Monica Arenas, Zubair H Khan, et al.
American Journal of Human Genetics|March 6, 2003
Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn diseaseMuddassar M Mirza, Sheila A Fisher, Kathy King, et al.
Pageof 8